NCT01532284View on ClinicalTrials.gov

The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis

NACompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

September 30, 2017

Conditions
Aneuploid Oocytes
Interventions
OTHER

Polar Body Biopsy

PB biopsy (PBB) will be performed between 9 and 12 hours after ICSI using laser or the mechanical procedure. PB1 and PB2 will be removed simultaneously (both at the same time) and transferred to different tubes for the chromosomal analysis.

Trial Locations (8)

Unknown

Centre for Reproductive Medicine BRUSSELSIVF and Centre Medical Genetics, Vrije Universiteit Brussel, Brussels

Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany, Bonn

gyn-medicum Göttingen; Zentrum für Kinderwunsch, Göttingen

UNIVERSITÄTSKLINIKUM Schleswig-Holstein - Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Lübeck

Department of Medical Genetics, Athens University/Genesis Athens Clinic, Greece, Athens

Medical Genetics Institute, Shaare Zedek Medical Center and IVF Unit, Jerusalem

Department of Reproductive Medicine, S.I.S.Me.R., Reproductive Medicine Unit,, Bologna

Institut Universitari Dexeus, Barcelona

All Listed Sponsors
lead

European Society of Human Reproduction and Embryology

OTHER

NCT01532284 - The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis | Biotech Hunter | Biotech Hunter